Navigation Links
Terramera PlantScience Acquires Plasma Power
Date:9/3/2014

Vancouver, B.C. (PRWEB) September 03, 2014

Ag/Bio Tech company Terramera PlantScience announced today the acquisition of Plasma Power, an India-based manufacturer of Cold Pressed Neem Oil and other ecologically friendly products for use in agriculture, human health and cosmetic applications. Plasma Power, headquartered in Chennai India, produces a range of products for use agricultural crop protection including the only US EPA registered cold pressed neem oil for use as a pesticide. Plasma Power’s Cold Pressed Neem Oil is the active ingredient in Terramera’s leading biopesticides which include Proof® plant-based insecticides, and CIRKIL® professional products.

Plasma Power was founded in 1987 and has been focusing on the development of Neem and other natural products since 1996. They have perfected the process of cold pressed Neem Oil extraction and hold its patent. Their products include certified organic Cold Pressed Neem oil, Neem cake, Karanja oil and Karanja cake. Terramera will continue Plasma Power’s operation in India with the existing staff and facilities, serving the Plasma’s current global customer base and will invest to grow the business aggressively.

“The acquisition of Plasma gives Terramera PlantScience security with the only EPA registered source of Cold Pressed Neem Oil and guarantees supply of the key active ingredient in our current biopesticide products,” said Karn Manhas, CEO and founder of Terramera. “It also provides a profitable going concern with a global customer base, and an opportunity to expand use of neem products globally—both through Terramera and with Plasma’s customers—for biopesticides, health and cosmetic applications.”

“Terramera PlantScience has active field trials and a solid pipeline of products in development using Cold Pressed Neem Oil from Plasma Power,” said Manhas, “this acquisition will allow Terramera to accelerate development and regulatory approval processes through this vertical integration of our active ingredient source.”

This acquisition will allow Terramera PlantScience to accelerate development and production of neem, neem products, and better biopesticides. The company will strive to increase the supply of the highest standard of quality cold-pressed neem around the world for all uses.

Media Contacts:

Karn Manhas, CEO
Terramera PlantScience
karn@terrramera.com
(800) 597-9509
(604) 343-5553    

Maxwell Samuel, Country Manager
Terramera Biosciences (India) Private Limited
maxwell@plasmaneem.com

About Terramera PlantScience: Terramera is the leader in developing revolutionary plant-based products that are a highly effective, minimal-toxicity means of pest management. The company’s flagship products include Proof® and CIRKIL®, EPA-registered biopesticides for control of bed bugs and other household pests. Terramera’s product pipeline includes biopesticides for agricultural use in a variety of crops and applications for bee health. Terramera was highlighted as a leader with potential to dominate the biopesticides market in a recent report by LUX research, an independent research and advisory firm which identified biopesticides as a “hot” industry, predicting growth into a multi billion-dollar market. Terramera is a Vancouver, Canada based company founded in 2009 with the mission to provide safe and innovative pest management products for every person and family. For more information about Terramera, visit our websites at http://www.terramera.com and at http://www.plasmaneem.com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12133547.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. PlantCellCulture.com Launched by DianaPlantSciences to Educate Industry and Consumers About Benefits of Plant Cell Culture Technology
2. Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen
3. SP Industries Acquires Bel-Art Products
4. Kainos Capital Acquires Slim-Fast From Unilever
5. WaferGen Bio-systems Acquires a Leading Next-Generation Sequencing (NGS) Library Preparation Business and Announces Changes to its Board of Directors
6. Decision Resources Group Acquires Relay Technology Management
7. Neogen acquires Chem-Tech
8. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
9. NSF International Acquires Brazil’s Bioensaios Analysis and Environmental Consultancy Ltd., a Leading Analytical Laboratory
10. Neogen acquires Prima Tech
11. RGF Environmental Group Acquires AFL Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Research and Markets has ... report to their offering. ... The Global Market for Bioproducts ... 2016 at a CAGR of 8.9%, This ... bioproducts into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
Breaking Biology Technology:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
Breaking Biology News(10 mins):